FAS and T-cell non-Hodgkin lymphoma: Such aberrant methylation has been reported in Fas promoter in T-cell lymphoma or in colon carcinoma cell lines and also correlated to a decrease in Fas expression, thus conferring apoptosis resistance independently of the p53 status.